Marc Webster

2.9k total citations · 1 hit paper
31 papers, 2.3k citations indexed

About

Marc Webster is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Marc Webster has authored 31 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Marc Webster's work include HER2/EGFR in Cancer Research (11 papers), Advanced Breast Cancer Therapies (4 papers) and Cancer Treatment and Pharmacology (4 papers). Marc Webster is often cited by papers focused on HER2/EGFR in Cancer Research (11 papers), Advanced Breast Cancer Therapies (4 papers) and Cancer Treatment and Pharmacology (4 papers). Marc Webster collaborates with scholars based in Canada, United States and Spain. Marc Webster's co-authors include Robert D. Cardiff, WJ Muller, Michael D. Schaller, Chantale T. Guy, Tessa J. Parsons, William J. Muller, Peter M. Siegel, Senthil K. Muthuswamy, David Dankort and Richard J. Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Marc Webster

29 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

1992 964 citations Marc Webster, Robert D. Cardiff et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc Webster Canada	14	1.3k	1.2k	424	325	296	31	2.3k
Ka Yin Kwong United States	14	1.2k 0.9×	1.7k 1.4×	339 0.8×	272 0.8×	183 0.6×	17	2.7k
Thomas Holbro Switzerland	11	1.3k 0.9×	1.3k 1.1×	672 1.6×	196 0.6×	120 0.4×	17	2.3k
Steve Coats United States	13	1.4k 1.1×	1.6k 1.3×	137 0.3×	324 1.0×	392 1.3×	18	2.3k
Azucena Esparís‐Ogando Spain	27	861 0.7×	1.3k 1.1×	310 0.7×	171 0.5×	198 0.7×	45	2.0k
Ying‐Nai Wang United States	24	955 0.7×	1.7k 1.3×	214 0.5×	426 1.3×	260 0.9×	44	2.5k
Jean Gudas United States	25	945 0.7×	1.3k 1.0×	106 0.3×	345 1.1×	161 0.5×	44	2.1k
Simonetta Buglioni Italy	22	772 0.6×	930 0.8×	144 0.3×	188 0.6×	130 0.4×	71	1.7k
Paul Meltzer United States	7	768 0.6×	1.8k 1.5×	122 0.3×	233 0.7×	190 0.6×	10	2.4k
Cammie Rinehart United States	15	1.7k 1.3×	1.7k 1.4×	719 1.7×	208 0.6×	126 0.4×	19	2.8k
Yan M. Li United States	7	1.1k 0.8×	1.4k 1.1×	77 0.2×	297 0.9×	174 0.6×	8	2.1k

Countries citing papers authored by Marc Webster

Since Specialization

Citations

This map shows the geographic impact of Marc Webster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Webster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Webster more than expected).

Fields of papers citing papers by Marc Webster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Webster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Webster. The network helps show where Marc Webster may publish in the future.

Co-authorship network of co-authors of Marc Webster

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Webster. A scholar is included among the top collaborators of Marc Webster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Webster. Marc Webster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brezden‐Masley, Christine, et al.. (2025). Clinician’s guide: expert insights on the use of CDK4/6 inhibitors in patients with early breast cancer. Therapeutic Advances in Medical Oncology. 17. 22771446–22771446.

Escrivá-de-Romaní, Santiago, Juan Miguel Cejalvo, Emilio Alba, et al.. (2025). Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a study. The Lancet Oncology. 26(6). 745–758. 2 indexed citations

Gelmon, Karen A., Jean-François Boileau, Christine Brezden‐Masley, et al.. (2024). Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting. Current Oncology. 31(11). 6536–6567. 1 indexed citations

Kornaga, Elizabeth, Alexander C. Klimowicz, Travis Ogilvie, et al.. (2016). A systematic comparison of three commercial estrogen receptor assays in a single clinical outcome breast cancer cohort. Modern Pathology. 29(8). 799–809. 19 indexed citations

McNeely, Margaret L., Kristin L. Campbell, Marc Webster, et al.. (2016). Efficacy of night-time compression for breast cancer related lymphedema (LYNC): protocol for a multi-centre, randomized controlled efficacy trial. BMC Cancer. 16(1). 601–601. 9 indexed citations

Taggar, Amandeep, Roderick H.W. Simpson, Desirée Hao, et al.. (2016). Secondary Neuroendocrine Carcinoma Following High-Dose Radiotherapy for Head and Neck Cancer: Report of Two Cases. Cureus. 8(10). e847–e847. 3 indexed citations

Kornaga, Elizabeth, Alexander C. Klimowicz, Travis Ogilvie, et al.. (2016). Evaluation of three commercial progesterone receptor assays in a single tamoxifen-treated breast cancer cohort. Modern Pathology. 29(12). 1492–1500. 9 indexed citations

Adatia, Feisal A., et al.. (2014). Treatment of ocular metastasis with anti-VEGF: A literature review and case report. Canadian Journal of Ophthalmology. 49(5). 458–463. 17 indexed citations

Harris, Jeffrey, Harold Lau, Neil Chua, et al.. (2014). Health Care Delivery for Head-and-Neck Cancer Patients in Alberta: A Practice Guideline. Current Oncology. 21(5). 704–714. 12 indexed citations

10.

Trotter, Theresa, et al.. (2010). A Teaching Model for Aromatase Inhibitors After Tamoxifen. Journal of Cancer Education. 25(4). 493–496. 2 indexed citations

11.

Langlois, Nicole, Marc Webster, James Jaffey, Josdalyne Anderson, & Philip S. Wells. (2005). Elevated factor VIII is a risk factor for idiopathic venous thromboembolism in Canada – is it necessary to define a new upper reference range for factor VIII?. Thrombosis and Haemostasis. 93(5). 842–846. 36 indexed citations

12.

Webster, Marc, Gregory Cairncross, S. Gertler, et al.. (2005). Phase II Trial of SarCNU in Malignant Glioma: Unexpected Pulmonary Toxicity with a Novel Nitrosourea. Investigational New Drugs. 23(6). 591–596. 5 indexed citations

13.

Lee, Richard J., Chris Albanese, Genichi Watanabe, et al.. (1999). pp60v- Induction of Cyclin D1 Requires Collaborative Interactions between the Extracellular Signal-regulated Kinase, p38, and Jun Kinase Pathways. Journal of Biological Chemistry. 274(11). 7341–7350. 202 indexed citations

14.

Webster, Marc, John N. Hutchinson, Michael J. Rauh, et al.. (1998). Requirement for Both Shc and Phosphatidylinositol 3′ Kinase Signaling Pathways in Polyomavirus Middle T-Mediated Mammary Tumorigenesis. Molecular and Cellular Biology. 18(4). 2344–2359. 174 indexed citations

15.

Webster, Marc, et al.. (1998). The induction of uterine leiomyomas and mammary tumors in transgenic mice expressing polyomavirus (PyV) large T (LT) antigen is associated with the ability of PyV LT antigen to form specific complexes with retinoblastoma and CUTL1 family members. Oncogene. 16(15). 1963–1972. 24 indexed citations

16.

Engelman, Jeffrey A., Richard J. Lee, Anthony N. Karnezis, et al.. (1998). Reciprocal Regulation of Neu Tyrosine Kinase Activity and Caveolin-1 Protein Expression in Vitro and in Vivo. Journal of Biological Chemistry. 273(32). 20448–20455. 191 indexed citations

17.

Muller, William J., Carlos L. Arteaga, Senthil K. Muthuswamy, et al.. (1996). Synergistic Interaction of the Neu Proto-Oncogene Product and Transforming Growth Factor α in the Mammary Epithelium of Transgenic Mice. Molecular and Cellular Biology. 16(10). 5726–5736. 113 indexed citations

18.

Lebel, Michel, Marc Webster, WJ Muller, et al.. (1996). Transgenic mice bearing the polyomavirus large T antigen directed by 2.1 kb of the Keratin 19 promoter develop bronchiolar papillary tumors with progression to lung adenocarcinomas. Lung Cancer. 14(2-3). 377–377. 8 indexed citations

19.

Webster, Marc, et al.. (1996). Tn5‐induced Xenorhabdus bovienii lecithinase mutants demonstrate reduced virulence for Galleria mellonella larvae. Journal of Applied Bacteriology. 80(4). 411–417. 5 indexed citations

20.

Munn, Robert J., Marc Webster, William J. Muller, & Robert D. Cardiff. (1995). Histopathology of transgenic mouse mammary tumors (a short atlas). Seminars in Cancer Biology. 6(3). 153–158. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact